Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- Indiana University
- Rutgers University
- THE UNIVERSITY OF HONG KONG
- University of Basel
- University of Florida
- University of Kansas Medical Center
- University of Minnesota
- Baylor College of Medicine
- Eli Lilly and Company
- Institute of Macromolecular Chemistry CAS
- Linköping University
- Lunenfeld-Tanenbaum Research Institute
- NEW YORK UNIVERSITY ABU DHABI
- Stanford University
- The Jackson Laboratory
- University of Copenhagen
- University of Utah
- University of Washington
- Università di Bologna
- Łukasiewicz Research Network - Krakow Institute of Technology
- 11 more »
- « less
-
Field
-
diabetes and multiple sclerosis. Immune checkpoint inhibition as well as chimeric antigen receptor T cells are being investigated as therapeutic options for restoring immunological tolerance. The post-holder
-
. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2 diabetes, metabolism, and/or
-
. For more information see: https://medicine.iu.edu/faculty-labs/witczak Successful candidates will have recently completed PhD training, possess a strong background in type 2 diabetes, metabolism, and/or
-
of Clinical Medicine, and the State Key Laboratory of Pharmaceutical Biotechnology Duties and Responsibilities Conduct research on chronic metabolic diseases, including obesity, diabetes, ageing, cardiovascular
-
metabolic diseases, including obesity, diabetes, ageing, cardiovascular diseases, metabolic dysfunction associated steatohepatitis (MASH), neurodegenerative disorders, and biostatistics Discover and
-
the impact of persistent chemical contaminants on immune tolerance mechanisms in type 1 diabetes using 3D models based on perinatal stem cells and human pancreatic islets" Type 1 diabetes (T1D) is an
-
Thesis based on ABIS. The main areas have so far been studies on the development of Type 1 diabetes, but also studies on celiac disease, JIA, IBD, autism, obesity, allergy and recently also psoriasis
-
of Copenhagen. For more information on the Department of Biomedical Sciences and the Lubberding group, visit https://bmi.ku.dk/english/ and https://bmi.ku.dk/english/research-divisions/integrative-circulation
-
, diabetes and cancer; see https://data.snf.ch/grants/grant/189065 ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a
-
, diabetes and metabolism. We have thematic interests in sterile inflammation and AI/ML-based computational biology. We expressly integrate new knowledge discoveries from genes and molecules to the whole